FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37451911000001107: Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
134121000001119 Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
134141000001112 Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Is a Metreleptin 11.3mg powder for solution for injection vials true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Is a Myalepta true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Has specific active ingredient Metreleptin true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Has dispensed dose form Powder for conventional release solution for injection true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) 30 vial Has AMP True Myalepta 11.3mg powder for solution for injection vials (Amryt Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start